Richard Ransohoff
Company: Third Rock Ventures LLC
Job title: Venture Partner
Seminars:
Adaptive Immunity Contributes to the Progressive Pathology of Multiple Sclerosis: Implications for Clinical Development 3:45 pm
• Progression Independent of Relapse Activity (PIRA) – what it is and why it matters. • Meningeal aggregates in MS – stable, pathogenic, resistant to current therapies • Imaging shows, for the first time, tissue injury associated with CNS compartmentalized progressive pathology of MSRead more
day: Day Two